Pediatric Endocrinology Diabetes and Metabolism
en ENGLISH
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
4/2025
vol. 31
 
Poleć ten artykuł:
Udostępnij:
Artykuł przeglądowy

Zespoły dysmorfii z nadmiernym wzrostem – przegląd systematyczny.  Część 1. – zespoły monogenowe

Julia Klaudia Gąsiorowska
1
,
Amelia Grundys
1
,
Laura Gawlik
1
,
Weronika Dziamara
1
,
Robert Stanisław Śmigiel
2
,
Beata Wikiera
2

  1. Faculty of Medicine, Wroclaw Medical University, Poland
  2. Department of Paediatrics, Endocrinology, Diabetology and Metabolic Diseases, Wroclaw Medical University, Poland
Pediatr Endocrinol Diabetes Metab 2025; 31 (4): 195-203
Data publikacji online: 2026/01/27
Plik artykułu:
Pobierz cytowanie
 
Metryki PlumX:
 
1. Śmigiel R, Szczałuba K, Krajewska-Walasek M. Dysmorfologia w praktyce pediatrycznej. Standardy Medyczne. Pediatria 2013; 10: 219–227.
2. Cerrolaza JJ, Porras AR, Mansoor A, et al. Identification of dysmorphic syndromes using landmark-specific local texture descriptors. Proc Int Symp Biomed Imaging 2016; 2016: 1080–1083. doi: 10.1109/ISBI.2016.7493453.
3. Borowiec A, Sarwińska M, Pyrżak BE. Zaburzenia wzrastania u dziecka – od pediatry do endokrynologa. Forum Pediatrii Praktycznej 2018. Available at: https://forumpediatrii.pl/artykul/zaburzenia-wzrastania-u-dziecka-od-pediatry-do-endokrynologa.
4. Verge CF, Mowat D. Overgrowth. Arch Dis Child 2010; 95: 458–463. doi: 10.1136/adc.2009.157693.
5. Bishara N, Clericuzio CL. Zespoły dysmorficzne często spotykane w oddziałach intensywnej terapii noworodków. Pediatria po Dyplomie 2009; 13: 70–82. Available at: https://podyplomie.pl/publish/system/articles/pdfarticles/000/012/598/original/70-82.pdf?1473325919 [Access: 7.03.2025].
6. # 117550. SOTOS SYNDROME; SOTOS. Available at: https://omim.org/entry/117550 [Access: 16.07.2025].
7. ORPHA:821. Sotos syndrome. Available at: https://www.orpha.net/en/disease/detail/821 [Access: 24.03.2025].
8. Foster A, Zachariou A, Loveday C, et al. The phenotype of Sotos syndrome in adulthood: a review of 44 individuals. Am J Med Genet C Semin Med Genet 2019; 181: 502–508. doi: 10.1002/ajmg.c.31738.
9. Lourdes VH, Mario SC, Didac CA, et al. Beyond the known phenotype of sotos syndrome: a 31-individuals cohort study. Front Pediatr 2023; 11: 1184529. doi: 10.3389/fped.2023.1184529.
10. Allanson JE. Sotos syndrome: Evolution of facial phenotype subjective and objective assessment. Am J Med Genet 1996; 70: 302–307.
11. Kurotaki N, Imaizumi K, Harada N, et al. Haploinsufficiency of NSD1 causes Sotos syndrome. Nat Genet 2002; 30: 365–366. doi: 10.1038/ng863.
12. # 130650. BECKWITH-WIEDEMANN SYNDROME; BWS. Available at: https://omim.org/entry/130650 [Access: 24.03.2025].
13. ORPHA:116. Beckwith-Wiedemann syndrome. Available at: https://www.orpha.net/en/disease/detail/116 [Access: 24.03.2025].
14. Borjas Mendoza PA, Daley SF, Mendez MD. Beckwith-Wiedemann Syndrome. 2024 Jan 7. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL) 2025.
15. Shuman C, Kalish JM, Weksberg R. Beckwith-Wiedemann Syndrome. [update: 2000 Mar 3]. In: Adam MP, Bick S, Mirzaa GM, et al. (eds.). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle 1993–2025.
16. Mishra D, Chakole V. Beckwith-Wiedemann syndrome. Pan Afr Med J 2023; 45: 17. doi: 10.11604/pamj.2023.45.17.38741. 
17. MedlinePlus. Simpson-Golabi-Behmel syndrome. Available at: https://medlineplus.gov/download/genetics/condition/simpson-golabi-behmel-syndrome.pdf [Access: 21.07.2025].
18. Baker Z, Cowan A, Hannallah A, et al. Bilateral Wilms’ tumor in a female with Simpson-Golabi-Behmel syndrome. Surg Case Rep 2022; 2022: 1–3. doi: 10.31487/j.SCR.2022.08.01.
19. Fernandes C, Paúl A, Venâncio MM, Ramos F. Simpson-Golabi-Behmel syndrome: One family, same mutation, different outcome. Am J Med Genet A 2021; 185: 2502–2506. doi: 10.1002/ajmg.a.62263. 
20. Xiang J, Zhang Q, Song X, et al. Whole exome sequencing aids the diagnosis of Simpson–Golabi–Behmel syndrome in two male fetuses. J Int Med Res 2019; 48: 0300060519859752. doi: 10.1177/0300060519859752.
21. Sha J, Tan F, Liu Y, et al. A prenatal case of Simpson-Golabi-Behmel syndrome type 1 with a 0.26-Mb deletion fragment at Xq26.2 inherited from mother: Case report. Medicine (Baltimore) 2022; 101: e29222. doi: 10.1097/MD.0000000000029222. 
22. Peng HH, Yu CJ, Chen YC, et al. Prenatal diagnosis of Simpson-Golabi-Behmel syndrome type 1 with an 814 kb Xq26.2 deletion with the initial presentation of a thick nuchal fold. Taiwan J Obstet Gynecol 2023; 62: 163–166. doi: 10.1016/j.tjog.2022.06.019.
23. Bu W, Zhu M, Li S, et al. Novel GPC3 gene mutation in Simpson-Golabi-Behmel syndrome with endocrine anomalies: A case report. Balkan J Med Genet 2022; 24: 95–98. doi: 10.2478/bjmg-2021-0024.
24. Rahiman EA, Bhat V, Kumar N, Mathai SS. Simpson-Golabi-Behmel syndrome type 1 in a neonate with central hepatoblastoma. BMJ Case Rep 2025; 18: e262331. doi: 10.1136/bcr-2024-262331.
25. Nisbet AF, Hathaway ER, Kalish JM. Simpson-Golabi-Behmel Syndrome Type 1. 2006 Dec 19 [updated 2024 Nov 14]. In: Adam MP, Bick S, Mirzaa GM, et al. (eds.). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle 1993–2025.
26. Watanabe K, Noguchi A, Takahashi I, et al. Precocious puberty in a case of Simpson–Golabi–Behmel syndrome with a de novo
27. 240-kb deletion including GPC3. Hum Genome Var 2022; 9: 23. doi: 10.1038/s41439-022-00196-8. 
28. Yehia L, Keel E, Eng C. The clinical spectrum of PTEN mutations. Annu Rev Med 2020; 71: 103–116. doi: 10.1146/annurev-med-052218-125823.
29. Kapačinskaitė M, Stratica N, Adomaitienė I, et al. A systematic review of Bannayan-Riley-Ruvalcaba syndrome. Sci Rep 2024; 14: 25391. doi: 10.1038/s41598-024-77082-6.
30. Iskandarli M, Yaman B, Aslan A. A case of Bannayan–Riley–Ruvalcaba syndrome. A new clinical finding and brief review. Int J Dermatol 2016; 55: 1040–1043. doi: 10.1111/ijd.13013. 
31. Lowichik A, White FV, Timmons CF, et al. Bannayan-Riley-Ruvalcaba syndrome: Spectrum of intestinal pathology including juvenile polyps. Pediatr Dev Pathol 2000; 3: 155–161. doi: 10.1007/s100240050019.
32. Munns CF, Batch JA. Hyperinsulinism and Beckwith-Wiedemann syndrome. Arch Dis Child Fetal Neonatal Ed 2001; 84: F67–69. doi: 10.1136/fn.84.1.f67.
33. Akcan T, Shariff JRR. Recurrent hypoglycemia secondary to insulinoma in an adult with Beckwith-Wiedemann syndrome. JCEM Case Rep 2023; 1:luad062. doi: 10.1210/jcemcr/luad062.
34. Fonville M, Pivnick E, Urraca N, et al. Atypical Sotos syndrome with normal length and late hyperinsulinemic hypoglycemia presentation. Genet Med Open 2023; 1: 100196. doi: 10.1016/j.gimo.2023.100196.
35. Verma A, Salehi P, Hing A, et al. Sotos syndrome with a novel mutation in the NSD1 gene associated with congenital hypothyroidism. Int J Pediatr Adolesc Med 2021; 8: 191–194. doi: 10.1016/j.ijpam.2020.06.001. 
36. Stoll C, Talon P, Mengus L, et al. A Weaver-like syndrome with endocrinological abnormalities in a boy and his mother. Clin Genet 1985; 28: 56–60. doi: 10.1111/j.1399-0004.1985.tb00396.x. 
37. Vincenzi G, Petralia IT, Abbate M, et al. Multinodular goiter in a patient with congenital hypothyroidism and Bannayan-Riley-Ruvalcaba syndrome: The possible synergic role of TPO and PTEN mutation. Front Endocrinol (Lausanne) 2023;14: 1205785. doi: 10.3389/fendo.2023.1205785.
38. Zhang J, Mu K, Xu H, et al. Simpson-Golabi-Behmel syndrome type 1 with subclinical hypothyroidism: A case report. Medicine (Baltimore) 2019; 98: e17616. doi: 10.1097/MD.0000000000017616.
39. Hendricks LAJ, Hoogerbrugge N, Schuurs-Hoeijmakers JHM, Vos JR. A review on age-related cancer risks in PTEN hamartoma tumor syndrome. Clin Genet 2021; 99: 219–225. doi: 10.1111/cge.13875.
40. ORPHA:109. Bannayan-Riley-Ruvalcaba syndrome. Available at: https://www.orpha.net/en/disease/detail/109 [Access: 24.03.2025].
41. Ngeow J, Sesock K, Eng C. Breast cancer risk and clinical implications for germline PTEN mutation carriers. Breast Cancer Res Treat 2017; 165: 1–8. doi: 10.1007/s10549-015-3665-z.
42. # 602535. MARSHALL-SMITH SYNDROME; MRSHSS. Available at: https://omim.org/entry/602535 [Access: 24.03.2025].
43. Adam MP, Hennekam RCM, Keppen LD, et al. Marshall-Smith syndrome: Natural history and evidence of an osteochondrodysplasia with connective tissue abnormalities. Am J Med Genet A 2005; 137: 117–124. doi: 10.1002/ajmg.a.30580.
44. Mulder PA, van Balkom IDC, Landlust AM, et al. Development, behaviour and sensory processing in Marshall–Smith syndrome and Malan syndrome: Phenotype comparison in two related syndromes. J Intellect Disabil Res 2020; 64: 956–969. doi: 10.1111/jir.12787.
45. ORPHA:561. Marshall-Smith syndrome. Available at: https://www.orpha.net/en/disease/detail/561 [Access: 16.03.2025].
46. ORPHA:3447. Weaver syndrome. Available at: https://www.orpha.net/en/disease/detail/3447 [Access: 16.03.2025].
47. MedlinePlus. Weaver syndrome. Available at: https://medlineplus.gov/genetics/condition/weaver-syndrome/ [Access: 24.03.2025].
48. Opitz JM, Weaver DW, Reynolds JF. The syndromes of Sotos and Weaver: Reports and review. J Med Genet 1998; 79: 233–240. doi: 10.1002/(sici)1096-8628(19981002)79:4<294::aid-ajmg12>3.0.co;2-m.
49. # 277590. WEAVER SYNDROME. Available at: https://www.omim.org/entry/277590 [Access: 24.03.2025].
50. Weaver syndrome. Available at: https://www.ncbi.nlm.nih.gov/medgen/120511 [Access: 24.03.2025].
51. ORPHA:221054. Acrocephalopolydactyly. Available at: https://www.orpha.net/en/disease/detail/221054 [Access: 23.07.2025].
52. Thornton CM, Stewart F. Elejalde syndrome: A case report. J Med Genet 1997; 69: 142–144. doi: 10.1002/(sici)1096-8628(19970414)
53. 69:4<406::aid-ajmg13>3.0.co;2-r.
54. # 225400. EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 1; EDSKSCL1. Available at: https://omim.org/entry/225400 [Access: 16.07.2025].
55. Voermans NC, Bönnemann CG, Lammens M, et al. Myopathy and polyneuropathy in an adolescent with the kyphoscoliotic type of Ehlers–Danlos syndrome. Am J Med Genet A 2009; 149A: 2311–2316. doi: 10.1002/ajmg.a.32997.
56. Yeowell H, Walker L. Ehlers-Danlos syndrome type VI results from a nonsense mutation and a splice site-mediated exon-skipping mutation in the lysyl hydroxylase gene. Proc Assoc Am Physicians 1997; 109: 383–396.
57. Giunta C, Randolph A, Al-Gazali LI, et al. Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers–Danlos syndrome (EDS VIA). Am J Med Genet A 2005; 133A: 158–164. doi: 10.1002/ajmg.a.30529. 
58. Salavoura K, Valari M, Kolialexi A, et al. A case of Ehlers-Danlos syndrome type VI. Genet Couns 2006; 17: 193–198.
59. Wilcox WR. Connective Tissue and Its Heritable Disorders: Molecular, Genetic, and Medical Aspects. Am J Hum Genet 2003; 72: 503–504.
60. # 615879. TATTON-BROWN-RAHMAN SYNDROMET; TBRS. Available at: https://omim.org/entry/615879 [Access: 07.01.2026].
61. Tatton-Brown K, Zachariou A, Loveday C, et al. The Tatton-Brown-Rahman syndrome: a clinical study of 55 individuals with de novo constitutive DNMT3A variants. Wellcome Open Res 2018; 3: 1–16. doi: 10.12688/wellcomeopenres.14430.1.
62. Ostrowski PJ, Tatton-Brown K. Tatton-Brown-Rahman syndrome. In: GeneReviews®. University of Washington, Seattle 2022.
63. Le Collen L, Charnay T, Ly S, et al. Tatton-Brown-Rahman syndrome: a new multiple endocrine neoplasia syndrome with intellectual disability? Ann Endocrinol (Paris) 2025; 86: 1–7. doi: 10.1016/j.ando.2024.101680.

© 2026 Termedia Sp. z o.o.
Developed by Bentus.